Home
Conditions
Endocrine Gland Neoplasms

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,100 public trials 1,371 recruiting studies

Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem

NCT02352337

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: CHU - Hôtel Dieu Angers, France

CH Auxerre, France

CH - Henri Duffaut Avignon, France

Centre d'oncologie et de radiothérapie Bayonne, France

View all 54 locations

View Trial Details

Completed

FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine

NCT02827201

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Clinique Privée Claude Bernard Albi, France

CH Blois, France

Clinique Tivoli Ducos Bordeaux, France

Hôpital Duchenne Boulogne-sur-Mer, France

View all 37 locations

View Trial Details

Completed

HRD Status Reference Standard Based on WGS

NCT06490380

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Lei Li Beijing, Beijing Municipality, China

View Trial Details

Completed

IMaging Pilot Study of the αvβ6 Integrin Radiotracer [18F]-A20FMDV2 in PAtients With Solid Cancer Types

NCT04285996

Conditions: Breast Diseases, Breast Neoplasms, Cancer, +11 more
Locations: Barts Health NHS Trust London, United Kingdom

View Trial Details

Completed

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

NCT03752398

Conditions: Adenocarcinoma, Advanced Solid Tumors, Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative, +95 more
Locations: UC San Diego Moores Cancer Center San Diego, California, United States

University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States

Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States

Florida Cancer Specialists Sarasota, Florida, United States

View all 18 locations

View Trial Details

Completed

Research on Nutritional Risk Indexes and Inflammatory Indicators in Postoperative Complications and Prognosis of Epithelial Ovarian Cancer Patients

NCT06483399

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations: Not specified

View Trial Details

Completed

Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation

NCT00673335

Conditions: Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +24 more
Locations: Institut Sainte Catherine Avignon, France

Centre Regional Francois Baclesse Caen, France

Centre Jean Perrin Clermont-Ferrand, France

Centre Oscar Lambret Lille, France

View all 23 locations

View Trial Details

Completed

Prospective Study of Clinically Nonfunctioning Pituitary Adenomas

NCT01556230

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +14 more
Locations: Columbia University Vagelos College of Physicians & Surgeons New York, United States

View Trial Details

Completed

An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy

NCT02310230

Conditions: Adenocarcinoma, Barrett Esophagus, Biliary Tract Diseases, +20 more
Locations: University of Vermont Medical Center Burlington, Vermont, United States

View Trial Details

Completed

Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma

NCT03077685

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

Parkview Cancer Institute Fort Wayne, Indiana, United States

Texas Tech University Health Sciences Center El Paso, Texas, United States

Baylor College of Medicine Houston, Texas, United States

View Trial Details

Endocrine Gland Neoplasms

Endocrine Gland Neoplasms trial results

Related conditions